Phathom Share Price
NASDAQ: PHAT | Small Cap | HealthcarePhathom Stock Performance
Phathom Share Price Today
As of 19 November 2026, Phathom Pharmaceuticals, Inc.'s share price is $5.22. The stock opened at $5.29, compared to its previous close of $5.48. During today's trading session, Phathom Pharmaceuticals, Inc.'s share price traded between $5.04 and $5.32, with an average price of $5.18. Over the past 52 weeks, the stock has recorded a high of $18.25 and a low of $5.04. In terms of performance, Phathom Pharmaceuticals, Inc.'s share price has declined by 45.63% over the last six months and is down 66.71% on a year-on-year basis.
Phathom Share Price Chart
Phathom Quarterly Profit & Loss
All figures in USD
Phathom Annual Profit & Loss
All figures in USD
Phathom Balance Sheet
All figures in USD Million
Phathom Cash Flow
All figures in USD Million
About Phathom
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
Phathom Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $5.75 | $5.22 | -8.98% |
Oct 2026 | $7.26 | $5.74 | -21.65% |
Sep 2026 | $9.62 | $7.32 | -18.07% |
Aug 2026 | $8.71 | $8.94 | +0.56% |
Jul 2026 | $10.91 | $8.88 | -18.19% |
Jun 2026 | $9.57 | $10.86 | +13.12% |
May 2026 | $11.44 | $9.60 | -13.86% |
Apr 2026 | $11.29 | $11.14 | +0.13% |
Mar 2026 | $12.09 | $11.13 | -11.42% |
Feb 2026 | $13.83 | $12.56 | -8.15% |
Jan 2026 | $16.52 | $13.68 | -17.59% |
Dec 2025 | $15.33 | $16.60 | +5.87% |